Anthropic Appoints Harvard Astrophysicist to Trust Controlling Its Board
Harvard astrophysicist Christopher Stubbs joins Anthropic's Long-Term Benefit Trust, the body that can elect a majority of its board, just weeks before an IPO that could top $2 trillion.
By Nathan Brooks
4 min read
Updated
What's News
- Anthropic named Harvard astrophysicist Christopher Stubbs to its Long-Term Benefit Trust, which can elect a majority of the seven-person board.
- Anthropic confidentially filed a draft IPO registration with the SEC in June; reports suggest a valuation above $2 trillion, up from $965 billion in May.
- Stubbs is the first physicist on the Trust, joining Ben Bernanke, Neil Buddy Shah and Richard Fontaine; one seat remains open.
- Anthropic said last weekend it will place 5% of its shares into a new Public Benefit Fund separate from the Trust.
Anthropic has named Harvard astrophysicist Christopher Stubbs to its Long-Term Benefit Trust, the body with the power to elect a majority of the AI company's board — and the arrangement is heading into its biggest stress test yet with an IPO widely expected as soon as next month.
The appointment fills one of two open seats on the Trust. Stubbs is best known for research showing that the universe's expansion is accelerating, a counterintuitive finding scientists attribute to a previously undocumented force known as "dark energy." He later headed the ESSENCE supernova cosmology project, which gathered further evidence on dark energy's nature.
His credentials stack up fast. In 2015, Stubbs and other members of the High-Z Supernova Search Team received the Breakthrough Prize in Fundamental Physics for the original dark energy findings. He was the first project scientist for what is now the Vera C. Rubin Observatory in Chile, which began a decade-long survey of the southern sky this past summer. He served as Harvard's Dean of Science from 2018 to 2024 and sits on JASON, the independent group of scientists advising the U.S. government on defense and technology.
Why an astrophysicist, and why now?
Daniela Amodei, Anthropic's cofounder and president, said Stubbs has a track record of following data and evidence "even when it went against the prevailing wisdom of the field." She added: "as AI starts to transform how science itself is done, [Stubbs'] intellectual honesty, rigor, and commitment to the truth are the values we want shaping the future of this technology, and I'm grateful he's bringing his deep expertise to the Trust."
Neil Buddy Shah, CEO of the Clinton Health Access Initiative and chair of the Trust, cited Stubbs's experience leading "large, complex, collaborative scientific endeavors across academia, government, and the national laboratories." Anthropic also noted that Stubbs has recently written about keeping AI-assisted research reproducible when AI models can give different answers to the same question.
Stubbs framed his motivation in personal terms. "I use AI tools in my research every day and see what they make possible, and as an educator I have confronted some of the hard questions they raise," he said in a statement. "As a grandfather, I want to help ensure that AI is developed and deployed for the long-term benefit of humanity."
He is the first physicist appointed to the Trust. He joins Shah; Richard Fontaine, CEO of the Center for a New American Security; and former Federal Reserve Chair Ben Bernanke, who came on board in July. The remaining vacancy opened in August, when former California Supreme Court Justice Mariano-Florentino Cuéllar left the Trust to become Anthropic's first chief global affairs officer.
What does this change for investors watching the IPO?
The Trust's power is drawing fresh scrutiny as the listing approaches. Anthropic confidentially filed a draft registration statement with the SEC in June. Reports suggest the IPO could value the company at more than $2 trillion — more than double the $965 billion valuation from its May funding round. The company has also reportedly planned super-voting shares for its founders. Critics say that structure, combined with the Trust, would leave public shareholders little say over the company's strategic direction.
The mechanics matter here. Anthropic is a Public Benefit Corporation, legally required to weigh its stated mission — "the responsible development and maintenance of advanced AI for the long-term benefit of humanity" — alongside shareholder returns. The Trust holds a special class of stock with no economic value. That stock gives it the right to elect a growing share of Anthropic's seven-person board, and eventually a majority. Trustees are independent of management and investors, and they advise leadership on major decisions, especially those involving AI's risks and impact on society.
There's one more moving part. Last weekend, Anthropic said it would place 5% of its shares into a new Public Benefit Fund — a vehicle separate from the Trust. The company said the fund would make donations to philanthropic organizations and possibly support people directly harmed by AI, such as workers who lost their jobs to AI-powered automation.
For practitioners, the signal is clear: Anthropic is reinforcing the governance layer that insulates its mission from market pressure right before it invites the market in — and how regulators, investors and exchanges respond to that combination will set a template other AI labs are likely to follow.
Original: linkedin.com
More from Nathan Brooks
Show full bio
News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.
1,078 articles